Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FLTN2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,763
Award facts
- Contract value 100% obligated
- $16,762.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,762.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, awarded on December 29, 2025, with an ultimate completion date of January 21, 2026, was issued under a firm fixed-price arrangement with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was recently awarded on November 13, 2025, with a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply operations across the Department of Defense's global healthcare network. DMS Pharmaceutical Group operates as a regional prime vendor contractor authorized to fulfill diverse pharmaceutical requirements, including branded and generic prescription medications, biologics, vaccines, and specialized medical consumables for military healthcare facilities worldwide. The company's performance on numerous prior delivery orders for high-value specialty pharmaceuticals, oncology treatments, and emergency medications demonstrates its operational capability to support the Defense Logistics Agency's mission-critical pharmaceutical supply chain for military medicine operations.
Quick answers
Who was awarded contract SPE2DR26FLTN2?
SPE2DR26FLTN2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FLTN2 worth?
The government has obligated $16,763 on SPE2DR26FLTN2.
Is contract SPE2DR26FLTN2 an order under another contract?
Yes. SPE2DR26FLTN2 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.
Was contract SPE2DR26FLTN2 competed?
The extent of competition for SPE2DR26FLTN2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award